• OPEN AN ACCOUNT
Indian Indices
Nifty
24,273.80 -140.60
(-0.58%)
Sensex
79,577.27 -757.54
( -0.94%)
Bank Nifty
54,365.65 -245.25
( -0.45%)
Nifty IT
36,002.45 82.15
( 0.23%)
Global Indices
Nasdaq
41,380.81 245.84
(0.60%)
Dow Jones
5,684.33 32.05
(0.57%)
Hang Seng
36,949.24 169.58
(0.46%)
Nikkei 225
8,531.61 -27.72
(-0.32%)
Forex
USD-INR
84.70 0.29
(0.35%)
EUR-INR
96.08 0.41
(0.42%)
GBP-INR
112.96 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Nestle India Ltd
Industry :  Food - Processing - MNC
BSE Code
ISIN Demat
Book Value()
500790
INE239A01024
42.7020188
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NESTLEIND
72.86
225718.83
EPS(TTM)
Face Value()
Div & Yield %
32.13
1
1.15
 

Glenmark launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC)
Mar 10,2025
Glenmark Therapeutics Inc., USA (Glenmark) announced the launch of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX®2 Powder for Solution, 17 grams of Bayer HealthCare LLC.

According to Nielsen® syndicated data for the latest 52 weeks' period ending 22 February 2025, the MiraLAX® Powder for Solution, 17 grams (OTC) market achieved annual sales of approximately $555.7 million.

Commenting on the launch, Marc Kikuchi, President & Business Head, North America said, “We are excited to announce the launch of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful, addressing the growing demand for a new supplier in this category. This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers.”